Noxopharm Ltd V.NOX

Primary Symbol: NOXOF

Healthcare Biotechnology

Noxopharm Limited is a biotech company. It is engaged in discovering and developing novel treatments for cancer and inflammation, including a pioneering technology to enhance messenger ribonucleic acid (mRNA) vaccines. It utilizes specialist in-house capabilities and partnerships with researchers to build a pipeline of new proprietary drugs based on two technology platforms: Chroma (oncology) and Sofra (inflammation, autoimmunity, and mRNA vaccine enhancement). Chroma is a technology platform focused on the development of multiple drug candidates, primarily for cancer treatment. The Sofra technology platform has a pipeline of proprietary drugs based on oligonucleotides, the building blocks of deoxyribonucleic acid (DNA), with a focus on mRNA vaccines and the treatment of autoimmune and inflammatory diseases. SOF-VAC has applications in the treatment of excessive inflammatory responses associated with specialized inflammatory receptors in the body known as Toll-like receptor 7.

OTCPK:NOXOF - Post by User

Noxopharm Ltd

Bullboard Posts

Comment by alixx11on Nov 23, 2009 12:34pm

696 Views

Post# 16514465

RE: RE: BNN Recommendation of NOX - Clip

I met a rep from AZK Alexandria at the recent Montreal resource show.

I asked him about the JV with NioGold. Instead of discussing it, he went into a long diatribe about why AZK is a better investment than NOX. The whole time he's trying to sell me on their properties, I'm looking at this huge map he had and seeing NioGold right across the street from the Osisko camp...

Be careful of companies that need to diss others to sell themselves.

Bullboard Posts

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!